| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.45 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |